GC16128
Clevidipine Butyrate
Also known as 5-O-(butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
Clevidipine Butyrate is a short-acting dihydropyridine calcium channel antagonist (IC50= 7·1 nM, V(H) = -40 mV ) under development for treatment of perioperative hypertension
ChemicalCAS167221-71-8MW456.32FormulaC21H23Cl2NO6
- CAS number
- 167221-71-8
- Molecular weight
- 456.32
- Formula
- C21H23Cl2NO6
- Solubility
- ≥ 21·4mg/mL in DMSO
- InChIKey
- KPBZROQVTHLCDU-UHFFFAOYSA-N
- Catalogue number
- GC16128
- Brand
- GLPBIO
Computed properties PubChem CID 153994 · XLogP 4.3 · TPSA 90.9 Ų · H-bond donors 1
- XLogP
- 4.3
- TPSA
- 90.9 Ų
- H-bond donors
- 1
- H-bond acceptors
- 7
- Rotatable bonds
- 10
- Heavy atoms
- 30
SMILES CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
Computed descriptors from PubChem (CID 153994), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il